Accumulation of APP-CTF induces mitophagy dysfunction in the iNSCs model of Alzheimer's disease
Related Experiment Video
Updated: Oct 7, 2025

Detecting Amyloid-β Accumulation via Immunofluorescent Staining in a Mouse Model of Alzheimer's Disease
Published on: April 19, 2021
Seung-Eun Lee1, Daekee Kwon2, Nari Shin1
1Adult Stem Cell Research Center and Research Institute for Veterinary Science, College of Veterinary Medicine, Seoul National University, Seoul, 08826, Republic of Korea.
Abstract:
Mitochondrial dysfunction is associated with familial Alzheimer's disease (fAD), and the accumulation of damaged mitochondria has been reported as an initial symptom that further contributes to disease progression. In the amyloidogenic pathway, the amyloid precursor protein (APP) is cleaved by β-secretase to generate a C-terminal fragment, which is then cleaved by γ-secretase to produce amyloid-beta (Aβ). The accumulation of Aβ and its detrimental effect on mitochondrial function are well known, yet the amyloid precursor protein-derived C-terminal fragments (APP-CTFs) contributing to this pathology have rarely been reported. We demonstrated the effects of APP-CTFs-related pathology using induced neural stem cells (iNSCs) from AD patient-derived fibroblasts. APP-CTFs accumulation was demonstrated to mainly occur within mitochondrial domains and to be both a cause and a consequence of mitochondrial dysfunction. APP-CTFs accumulation also resulted in mitophagy failure, as validated by increased LC3-II and p62 and inconsistent PTEN-induced kinase 1 (PINK1)/E3 ubiquitin ligase (Parkin) recruitment to mitochondria and failed fusion of mitochondria and lysosomes. The accumulation of APP-CTFs and the causality of impaired mitophagy function were also verified in AD patient-iNSCs. Furthermore, we confirmed this pathological loop in presenilin knockout iNSCs (PSEN KO-iNSCs) because APP-CTFs accumulation is due to γ-secretase blockage and similarly occurs in presenilin-deficient cells. In the present work, we report that the contribution of APP-CTFs accumulation is associated with mitochondrial dysfunction and mitophagy failure in AD patient-iNSCs as well as PSEN KO-iNSCs.
Insights
Amyloid precursor protein fragments (APP-CTFs) accumulate in mitochondria, causing dysfunction and mitophagy failure in Alzheimer's disease (AD) models. This study reveals APP-CTFs as a key factor in AD pathology, linking mitochondrial damage to disease progression.
Area of Science:
- Neuroscience
- Cell Biology
- Genetics
Background:
- Mitochondrial dysfunction is a known hallmark of familial Alzheimer's disease (fAD).
- Amyloid precursor protein (APP) processing generates amyloid-beta (Aβ), but the role of other APP fragments in pathology is less understood.
- Accumulation of damaged mitochondria contributes to Alzheimer's disease (AD) progression.
Purpose of the Study:
- To investigate the role of amyloid precursor protein-derived C-terminal fragments (APP-CTFs) in mitochondrial dysfunction and mitophagy in Alzheimer's disease.
- To elucidate the pathological mechanisms involving APP-CTFs in induced neural stem cells (iNSCs) from AD patients and presenilin knockout models.
Main Methods:
- Utilized induced neural stem cells (iNSCs) derived from Alzheimer's disease (AD) patient fibroblasts.
- Analyzed APP-CTFs accumulation within mitochondrial domains.
- Assessed mitophagy failure using markers like LC3-II, p62, and PTEN-induced kinase 1 (PINK1)/Parkin.
- Validated findings in presenilin knockout iNSCs (PSEN KO-iNSCs) to confirm the role of gamma-secretase activity.
Main Results:
- Demonstrated that APP-CTFs accumulate within mitochondria, acting as both a cause and consequence of mitochondrial dysfunction.
- Showed that APP-CTFs accumulation leads to mitophagy failure, evidenced by altered protein levels and impaired mitochondrial-lysosomal fusion.
- Confirmed the pathological loop of APP-CTFs accumulation and mitophagy impairment in both AD patient-derived iNSCs and PSEN KO-iNSCs.
Conclusions:
- APP-CTFs accumulation is a significant contributor to mitochondrial dysfunction and mitophagy failure in Alzheimer's disease.
- The findings highlight a novel pathological mechanism involving APP-CTFs in AD, distinct from solely Aβ toxicity.
- Targeting APP-CTFs or enhancing mitophagy may offer new therapeutic strategies for Alzheimer's disease.
Related Concept Videos
Autophagy
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
Autophagic Cell Death
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...

